CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $334,220 | +23.4% | 20,158 | +38.4% | 0.02% | +11.1% |
| Q4 2022 | $270,835 | -10.3% | 14,561 | -38.0% | 0.02% | -10.0% |
| Q3 2022 | $302,000 | -60.0% | 23,504 | -83.5% | 0.02% | -52.4% |
| Q3 2021 | $755,000 | -4.3% | 142,529 | +3.9% | 0.04% | 0.0% |
| Q2 2021 | $789,000 | +39.9% | 137,216 | +12.1% | 0.04% | +31.2% |
| Q1 2021 | $564,000 | +96.5% | 122,419 | +42.6% | 0.03% | +52.4% |
| Q4 2020 | $287,000 | +63.1% | 85,874 | +45.0% | 0.02% | +250.0% |
| Q3 2020 | $176,000 | +175.0% | 59,234 | +375.6% | 0.01% | +500.0% |
| Q1 2019 | $64,000 | – | 12,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |